FDA
approval
· 2022-04-29
FDA Approved: NORTREL 28 DAY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
The FDA approved a supplemental application for Nortrel 28 Day (norethindrone and ethinyl estradiol) from Teva Pharmaceuticals USA, Inc. under ANDA072696.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NORTREL 28 DAY (NORETHINDRONE AND ETHINYL ESTRADIOL)